Adventitial fibroblast-derived vascular endothelial growth factor promotes vasa vasorum-associated neointima formation and macrophage recruitment

Cardiovasc Res. 2020 Mar 1;116(3):708-720. doi: 10.1093/cvr/cvz159.

Abstract

Aims: Adventitial vasa vasorum provides oxygen and nourishment to the vascular wall, but whether it regulates vascular disease remains unclear. We have previously shown that an increased expression of VEGF (vascular endothelial growth factor) is associated with macrophage infiltration. This study aims to determine whether adventitial fibroblast (AF)-derived VEGF increases the number of vasa vasorum contributing to neointima formation through macrophage recruitment.

Methods and results: In rat balloon injury model, vasa vasorum count was increased particularly in the adventitia accompanied by cell proliferation and VEGF expression. Both endogenous and PKH26-labelled exogenous macrophages were mainly distributed in adventitia around vasa vasorum. Interestingly, perivascular delivery of Ranibizumab preferentially concentrated in adventitia resulted in a decrease of neointima formation with concurrent reduction of vasa vasorum count and macrophage infiltration. AFs with adenovirus-mediated VEGF over-expression delivered to the adventitia significantly enhanced these pathological changes after injury. In Tie2-cre/Rosa-LoxP-RFP mice, endothelial cells were increased in the adventitia after wire injury. By using multiphoton laser scanning microscopy, macrophage rolling, adhesion and transmigration were observed in vasa vasorum. Moreover, adoptive transfer of macrophages accelerated injury-induced neointima formation. VEGF-neutralizing antibody administration also attenuated wire injury-induced neointima formation and macrophage infiltration. In primary cultured AFs, exogenous VEGF increased VEGF expression and secretion in a time- and dose-dependent manner. AF-conditioned medium promoted endothelial cell angiogenesis, vascular cell adhesion molecule-1 expression and macrophage adhesion was blocked by VEGF-neutralizing antibody and VEGFR2 inhibitor ZM323881, which also inhibited activation of VEGFR2/ERK1/2 pathway.

Conclusion: These results demonstrate that AF-derived VEGF plays a significant role in the increase of vasa vasorum count which is involved in macrophage recruitment and neointima formation.

Keywords: Adventitial fibroblast; Macrophage; Neointimal hyperplasia; Vasa vasorum; Vascular endothelial growth factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer
  • Adventitia / drug effects
  • Adventitia / metabolism*
  • Adventitia / pathology
  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Carotid Arteries / drug effects
  • Carotid Arteries / metabolism*
  • Carotid Arteries / pathology
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / metabolism*
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / prevention & control
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Female
  • Femoral Artery / drug effects
  • Femoral Artery / metabolism*
  • Femoral Artery / pathology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Macrophages / pathology
  • Macrophages / transplantation
  • Male
  • Mice, Inbred C57BL
  • Neointima*
  • Paracrine Communication
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Tissue Culture Techniques
  • Vasa Vasorum / drug effects
  • Vasa Vasorum / metabolism*
  • Vasa Vasorum / pathology
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular System Injuries / genetics
  • Vascular System Injuries / metabolism*
  • Vascular System Injuries / pathology
  • Vascular System Injuries / prevention & control

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • vascular endothelial growth factor A, rat